Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Saccades | 35 | 2016 | 235 | 5.820 |
Why?
|
Schizophrenia | 69 | 2024 | 6983 | 4.480 |
Why?
|
Psychomotor Performance | 25 | 2024 | 1892 | 2.650 |
Why?
|
Sleep | 29 | 2024 | 4819 | 2.540 |
Why?
|
Sleep Stages | 11 | 2024 | 706 | 2.100 |
Why?
|
Reaction Time | 32 | 2014 | 2101 | 1.860 |
Why?
|
Memory, Short-Term | 20 | 2022 | 1008 | 1.760 |
Why?
|
Gyrus Cinguli | 10 | 2014 | 1135 | 1.620 |
Why?
|
Brain Mapping | 32 | 2024 | 6685 | 1.560 |
Why?
|
Schizophrenic Psychology | 19 | 2018 | 1649 | 1.320 |
Why?
|
Magnetoencephalography | 8 | 2014 | 641 | 1.250 |
Why?
|
Functional Laterality | 17 | 2018 | 2264 | 1.240 |
Why?
|
Nerve Net | 15 | 2019 | 2352 | 1.220 |
Why?
|
Polysomnography | 10 | 2024 | 1871 | 1.160 |
Why?
|
Cerebral Cortex | 14 | 2024 | 5812 | 1.140 |
Why?
|
Memory | 11 | 2024 | 2208 | 1.100 |
Why?
|
Electroencephalography | 24 | 2024 | 6314 | 1.090 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 4 | 2014 | 276 | 1.070 |
Why?
|
Brain Waves | 6 | 2024 | 417 | 0.980 |
Why?
|
Attention | 13 | 2022 | 2424 | 0.970 |
Why?
|
Thalamus | 8 | 2024 | 1047 | 0.920 |
Why?
|
Magnetic Resonance Imaging | 62 | 2024 | 36743 | 0.880 |
Why?
|
Neural Pathways | 13 | 2022 | 3117 | 0.870 |
Why?
|
Prefrontal Cortex | 15 | 2016 | 2238 | 0.870 |
Why?
|
Brain | 34 | 2024 | 27360 | 0.860 |
Why?
|
Photic Stimulation | 17 | 2013 | 1997 | 0.780 |
Why?
|
Child Development Disorders, Pervasive | 4 | 2014 | 598 | 0.770 |
Why?
|
Mental Processes | 3 | 2016 | 246 | 0.740 |
Why?
|
Executive Function | 4 | 2016 | 1401 | 0.730 |
Why?
|
Frontal Lobe | 7 | 2016 | 1426 | 0.640 |
Why?
|
Pattern Recognition, Visual | 5 | 2012 | 826 | 0.630 |
Why?
|
Thalamic Nuclei | 1 | 2019 | 110 | 0.620 |
Why?
|
Body Dysmorphic Disorders | 1 | 2022 | 243 | 0.610 |
Why?
|
Dominance, Cerebral | 4 | 2007 | 623 | 0.600 |
Why?
|
Neuropsychological Tests | 28 | 2024 | 7140 | 0.570 |
Why?
|
Cognition Disorders | 11 | 2017 | 3980 | 0.540 |
Why?
|
Aquatic Organisms | 1 | 2016 | 42 | 0.520 |
Why?
|
Orientation | 3 | 2007 | 320 | 0.510 |
Why?
|
Birds | 1 | 2016 | 166 | 0.500 |
Why?
|
Adult | 97 | 2024 | 223646 | 0.500 |
Why?
|
Learning | 5 | 2022 | 1759 | 0.490 |
Why?
|
Autistic Disorder | 6 | 2022 | 1240 | 0.480 |
Why?
|
Endophenotypes | 2 | 2017 | 259 | 0.470 |
Why?
|
Feedback, Psychological | 3 | 2011 | 97 | 0.460 |
Why?
|
Visual Fields | 3 | 2014 | 1065 | 0.450 |
Why?
|
Cognition | 13 | 2023 | 7073 | 0.440 |
Why?
|
Male | 105 | 2024 | 364719 | 0.440 |
Why?
|
Azabicyclo Compounds | 1 | 2013 | 68 | 0.430 |
Why?
|
Video Games | 1 | 2016 | 202 | 0.430 |
Why?
|
Epilepsy, Rolandic | 2 | 2024 | 57 | 0.410 |
Why?
|
Humans | 136 | 2024 | 768166 | 0.390 |
Why?
|
Psychotic Disorders | 2 | 2024 | 3276 | 0.390 |
Why?
|
Female | 101 | 2024 | 397192 | 0.390 |
Why?
|
Obsessive-Compulsive Disorder | 3 | 2018 | 1508 | 0.380 |
Why?
|
Volition | 2 | 2010 | 61 | 0.360 |
Why?
|
Evoked Potentials | 2 | 2014 | 1058 | 0.360 |
Why?
|
Diffusion Magnetic Resonance Imaging | 7 | 2018 | 2815 | 0.360 |
Why?
|
Mammals | 1 | 2016 | 1135 | 0.350 |
Why?
|
Hypnotics and Sedatives | 2 | 2020 | 1191 | 0.350 |
Why?
|
Catechol O-Methyltransferase | 2 | 2009 | 251 | 0.340 |
Why?
|
Intention | 1 | 2013 | 347 | 0.340 |
Why?
|
Young Adult | 31 | 2024 | 60066 | 0.330 |
Why?
|
Image Processing, Computer-Assisted | 16 | 2017 | 9015 | 0.320 |
Why?
|
Cerebrum | 1 | 2010 | 132 | 0.310 |
Why?
|
Asperger Syndrome | 3 | 2005 | 57 | 0.310 |
Why?
|
Behavior | 1 | 2011 | 542 | 0.310 |
Why?
|
Motor Cortex | 2 | 2014 | 1013 | 0.300 |
Why?
|
Stereotyped Behavior | 1 | 2008 | 133 | 0.300 |
Why?
|
Memory Disorders | 6 | 2015 | 1200 | 0.280 |
Why?
|
Motor Skills | 3 | 2024 | 523 | 0.280 |
Why?
|
Neural Conduction | 1 | 2008 | 443 | 0.270 |
Why?
|
Fixation, Ocular | 1 | 2007 | 243 | 0.260 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2015 | 1107 | 0.260 |
Why?
|
Thinking | 3 | 2016 | 320 | 0.250 |
Why?
|
Middle Aged | 53 | 2024 | 223492 | 0.250 |
Why?
|
Form Perception | 2 | 2004 | 175 | 0.250 |
Why?
|
Evoked Potentials, Motor | 2 | 2008 | 465 | 0.250 |
Why?
|
Motor Activity | 2 | 2018 | 2711 | 0.250 |
Why?
|
Perceptual Disorders | 1 | 2007 | 199 | 0.250 |
Why?
|
Analysis of Variance | 10 | 2014 | 6229 | 0.240 |
Why?
|
Social Perception | 3 | 2009 | 434 | 0.240 |
Why?
|
Mental Recall | 2 | 2015 | 1226 | 0.230 |
Why?
|
Hippocampus | 3 | 2024 | 3785 | 0.230 |
Why?
|
Choice Behavior | 2 | 2011 | 848 | 0.230 |
Why?
|
Wakefulness | 4 | 2022 | 1284 | 0.230 |
Why?
|
Genetic Predisposition to Disease | 8 | 2022 | 18065 | 0.230 |
Why?
|
Face | 2 | 2007 | 1029 | 0.230 |
Why?
|
Prosopagnosia | 1 | 2004 | 64 | 0.220 |
Why?
|
Nerve Fibers, Myelinated | 2 | 2012 | 952 | 0.220 |
Why?
|
Dyslexia | 2 | 2022 | 215 | 0.210 |
Why?
|
Parietal Lobe | 2 | 2010 | 866 | 0.210 |
Why?
|
Piperazines | 1 | 2013 | 2554 | 0.210 |
Why?
|
Adolescent | 26 | 2024 | 89169 | 0.200 |
Why?
|
Reference Values | 6 | 2012 | 4938 | 0.200 |
Why?
|
Amnesia | 1 | 2024 | 257 | 0.190 |
Why?
|
Amygdala | 2 | 2009 | 1380 | 0.190 |
Why?
|
Affective Symptoms | 1 | 2004 | 418 | 0.190 |
Why?
|
Visual Cortex | 2 | 2007 | 1094 | 0.190 |
Why?
|
Antipsychotic Agents | 10 | 2017 | 3081 | 0.190 |
Why?
|
Visual Perception | 3 | 2018 | 1402 | 0.190 |
Why?
|
Occipital Lobe | 1 | 2022 | 376 | 0.180 |
Why?
|
Task Performance and Analysis | 6 | 2016 | 771 | 0.180 |
Why?
|
Space Perception | 1 | 2004 | 466 | 0.180 |
Why?
|
Diazepam | 1 | 2021 | 214 | 0.180 |
Why?
|
Models, Neurological | 5 | 2011 | 1776 | 0.170 |
Why?
|
Acoustic Stimulation | 2 | 2023 | 1255 | 0.170 |
Why?
|
Case-Control Studies | 10 | 2024 | 22291 | 0.170 |
Why?
|
Ataxia | 1 | 2022 | 307 | 0.170 |
Why?
|
Eye Movement Measurements | 2 | 2010 | 32 | 0.170 |
Why?
|
Epilepsy, Generalized | 1 | 2022 | 181 | 0.160 |
Why?
|
Fingers | 2 | 2014 | 511 | 0.160 |
Why?
|
Leukoencephalopathies | 2 | 2012 | 259 | 0.160 |
Why?
|
Social Behavior | 2 | 2005 | 1147 | 0.160 |
Why?
|
Cues | 5 | 2015 | 878 | 0.150 |
Why?
|
Child | 14 | 2024 | 80917 | 0.150 |
Why?
|
Alleles | 4 | 2014 | 6894 | 0.150 |
Why?
|
Neural Inhibition | 1 | 2002 | 588 | 0.150 |
Why?
|
Polymorphism, Genetic | 1 | 2008 | 4249 | 0.150 |
Why?
|
Anisotropy | 3 | 2012 | 1292 | 0.150 |
Why?
|
Basal Ganglia | 1 | 2000 | 553 | 0.140 |
Why?
|
Cross-Over Studies | 2 | 2020 | 2107 | 0.140 |
Why?
|
DNA Methylation | 1 | 2011 | 4428 | 0.140 |
Why?
|
Double-Blind Method | 5 | 2020 | 12465 | 0.140 |
Why?
|
Epilepsies, Partial | 1 | 2021 | 435 | 0.140 |
Why?
|
Tetrahydrofolates | 1 | 2017 | 58 | 0.140 |
Why?
|
Imaging, Three-Dimensional | 2 | 2007 | 4063 | 0.130 |
Why?
|
Amobarbital | 1 | 1996 | 43 | 0.130 |
Why?
|
Dexmedetomidine | 1 | 2020 | 320 | 0.130 |
Why?
|
Rest | 3 | 2018 | 948 | 0.130 |
Why?
|
GABA Modulators | 1 | 1996 | 109 | 0.130 |
Why?
|
Regression Analysis | 3 | 2013 | 6340 | 0.130 |
Why?
|
Dopamine | 2 | 2016 | 1592 | 0.130 |
Why?
|
Anticipation, Psychological | 1 | 2016 | 91 | 0.120 |
Why?
|
Genotype | 5 | 2017 | 13045 | 0.120 |
Why?
|
Psychiatric Status Rating Scales | 11 | 2017 | 6029 | 0.120 |
Why?
|
Oxygen | 7 | 2013 | 4270 | 0.120 |
Why?
|
Receptors, Dopamine D1 | 1 | 2016 | 277 | 0.120 |
Why?
|
Models, Psychological | 2 | 2011 | 825 | 0.120 |
Why?
|
Ocular Motility Disorders | 2 | 2007 | 144 | 0.120 |
Why?
|
Brain Diseases | 2 | 2021 | 1554 | 0.120 |
Why?
|
Polymorphism, Single Nucleotide | 6 | 2017 | 16045 | 0.110 |
Why?
|
Schizophrenic Language | 1 | 1994 | 57 | 0.110 |
Why?
|
Neurogranin | 1 | 2013 | 15 | 0.110 |
Why?
|
Receptors, Dopamine D4 | 1 | 2014 | 168 | 0.110 |
Why?
|
Family | 1 | 2024 | 3209 | 0.110 |
Why?
|
Image Interpretation, Computer-Assisted | 4 | 2012 | 3390 | 0.110 |
Why?
|
Intelligence | 2 | 2016 | 926 | 0.110 |
Why?
|
Time Factors | 6 | 2011 | 40218 | 0.100 |
Why?
|
Neurophysiology | 2 | 2024 | 145 | 0.100 |
Why?
|
Algorithms | 4 | 2010 | 14164 | 0.100 |
Why?
|
Cycloserine | 3 | 1999 | 118 | 0.100 |
Why?
|
Discrimination Learning | 3 | 2005 | 278 | 0.090 |
Why?
|
Anxiety | 2 | 2024 | 4672 | 0.090 |
Why?
|
Punishment | 1 | 2011 | 95 | 0.090 |
Why?
|
Electrooculography | 1 | 2010 | 113 | 0.090 |
Why?
|
Verbal Learning | 1 | 2012 | 465 | 0.090 |
Why?
|
Signal Transduction | 2 | 2016 | 23645 | 0.090 |
Why?
|
Temporal Lobe | 4 | 2012 | 1726 | 0.090 |
Why?
|
Neostriatum | 1 | 2011 | 236 | 0.090 |
Why?
|
Electrophysiological Phenomena | 1 | 2011 | 309 | 0.080 |
Why?
|
Kinesics | 1 | 2009 | 13 | 0.080 |
Why?
|
Substantia Nigra | 1 | 2011 | 346 | 0.080 |
Why?
|
Reproducibility of Results | 7 | 2016 | 20227 | 0.080 |
Why?
|
Knowledge | 1 | 2010 | 178 | 0.080 |
Why?
|
Corpus Striatum | 2 | 2016 | 1224 | 0.080 |
Why?
|
Genome-Wide Association Study | 4 | 2016 | 12795 | 0.080 |
Why?
|
Expressed Emotion | 1 | 2009 | 92 | 0.080 |
Why?
|
Parkinson Disease | 1 | 2002 | 2893 | 0.080 |
Why?
|
Aging | 2 | 2018 | 8744 | 0.070 |
Why?
|
Random Allocation | 2 | 2002 | 2396 | 0.070 |
Why?
|
Severity of Illness Index | 6 | 2014 | 15948 | 0.070 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2022 | 3729 | 0.070 |
Why?
|
Psychomotor Disorders | 1 | 2007 | 149 | 0.070 |
Why?
|
Emotions | 3 | 2024 | 2767 | 0.070 |
Why?
|
Tobacco Use Disorder | 1 | 2012 | 708 | 0.060 |
Why?
|
Social Behavior Disorders | 1 | 2005 | 100 | 0.060 |
Why?
|
Actigraphy | 1 | 2009 | 527 | 0.060 |
Why?
|
Information Dissemination | 1 | 2013 | 1143 | 0.060 |
Why?
|
Eye Movements | 1 | 2008 | 514 | 0.060 |
Why?
|
Diffusion Tensor Imaging | 2 | 2012 | 2420 | 0.060 |
Why?
|
Magnetics | 2 | 2005 | 597 | 0.060 |
Why?
|
Reward | 1 | 2011 | 981 | 0.060 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2011 | 1988 | 0.060 |
Why?
|
Pattern Recognition, Automated | 1 | 2010 | 993 | 0.060 |
Why?
|
Bipolar Disorder | 2 | 2019 | 5130 | 0.060 |
Why?
|
Principal Component Analysis | 3 | 2012 | 948 | 0.060 |
Why?
|
Linear Models | 3 | 2016 | 5884 | 0.050 |
Why?
|
Animals | 4 | 2020 | 169246 | 0.050 |
Why?
|
Statistics as Topic | 1 | 2009 | 2357 | 0.050 |
Why?
|
Linguistics | 1 | 2022 | 110 | 0.050 |
Why?
|
Observer Variation | 2 | 2005 | 2622 | 0.050 |
Why?
|
Levodopa | 1 | 2002 | 221 | 0.050 |
Why?
|
Predictive Value of Tests | 3 | 2007 | 15454 | 0.050 |
Why?
|
Antiparkinson Agents | 1 | 2002 | 184 | 0.050 |
Why?
|
Motivation | 1 | 2011 | 2020 | 0.050 |
Why?
|
Language Development | 1 | 2022 | 183 | 0.050 |
Why?
|
Hemodynamics | 1 | 2011 | 4194 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2014 | 12077 | 0.040 |
Why?
|
Brief Psychiatric Rating Scale | 1 | 2000 | 108 | 0.040 |
Why?
|
Facial Expression | 1 | 2004 | 515 | 0.040 |
Why?
|
Auditory Perception | 2 | 2018 | 587 | 0.040 |
Why?
|
Tomography, Emission-Computed | 1 | 2003 | 1126 | 0.040 |
Why?
|
Fear | 1 | 2009 | 1495 | 0.040 |
Why?
|
Schizotypal Personality Disorder | 1 | 2000 | 289 | 0.040 |
Why?
|
Probability Learning | 1 | 2018 | 23 | 0.040 |
Why?
|
Affective Disorders, Psychotic | 1 | 2019 | 187 | 0.040 |
Why?
|
Cluster Analysis | 1 | 2004 | 2732 | 0.030 |
Why?
|
Developmental Disabilities | 1 | 2005 | 1518 | 0.030 |
Why?
|
Injections, Intra-Arterial | 1 | 1996 | 181 | 0.030 |
Why?
|
Kinetics | 1 | 2003 | 6329 | 0.030 |
Why?
|
Excitatory Amino Acid Agonists | 1 | 1995 | 142 | 0.030 |
Why?
|
Time | 1 | 1997 | 552 | 0.030 |
Why?
|
Smoking | 1 | 2012 | 9092 | 0.030 |
Why?
|
Infant | 2 | 2023 | 36535 | 0.030 |
Why?
|
Biological Clocks | 1 | 2016 | 321 | 0.030 |
Why?
|
DNA Copy Number Variations | 1 | 2022 | 2048 | 0.030 |
Why?
|
Child, Preschool | 3 | 2023 | 42669 | 0.030 |
Why?
|
Cerebrovascular Circulation | 1 | 2003 | 2725 | 0.030 |
Why?
|
Clozapine | 1 | 1996 | 509 | 0.030 |
Why?
|
Concept Formation | 1 | 1994 | 160 | 0.030 |
Why?
|
Aged | 7 | 2024 | 171504 | 0.030 |
Why?
|
Administration, Oral | 1 | 2020 | 4030 | 0.030 |
Why?
|
New Mexico | 1 | 2012 | 81 | 0.030 |
Why?
|
Spectrum Analysis | 1 | 2014 | 449 | 0.020 |
Why?
|
Nonlinear Dynamics | 1 | 2014 | 493 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2017 | 2862 | 0.020 |
Why?
|
Minnesota | 1 | 2012 | 339 | 0.020 |
Why?
|
Cross-Sectional Studies | 3 | 2024 | 26379 | 0.020 |
Why?
|
Problem Solving | 1 | 1994 | 443 | 0.020 |
Why?
|
Cohort Studies | 3 | 2024 | 41754 | 0.020 |
Why?
|
Syndrome | 1 | 1997 | 3272 | 0.020 |
Why?
|
Dreams | 1 | 1991 | 146 | 0.020 |
Why?
|
Folic Acid | 1 | 2017 | 1337 | 0.020 |
Why?
|
Models, Statistical | 1 | 2004 | 5107 | 0.020 |
Why?
|
Paralysis | 1 | 1991 | 250 | 0.020 |
Why?
|
Discriminant Analysis | 1 | 2009 | 222 | 0.020 |
Why?
|
Cerebral Ventricles | 1 | 2012 | 550 | 0.020 |
Why?
|
Meta-Analysis as Topic | 1 | 2014 | 1363 | 0.020 |
Why?
|
Seizures | 1 | 2022 | 2998 | 0.020 |
Why?
|
Epilepsy | 1 | 2024 | 3327 | 0.020 |
Why?
|
Homozygote | 1 | 2013 | 1779 | 0.020 |
Why?
|
Hallucinations | 1 | 1991 | 373 | 0.020 |
Why?
|
Research Design | 1 | 2024 | 6211 | 0.020 |
Why?
|
Sleep, REM | 1 | 1991 | 595 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2016 | 14729 | 0.020 |
Why?
|
Corpus Callosum | 1 | 2012 | 753 | 0.020 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 3 | 1999 | 903 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2014 | 1514 | 0.020 |
Why?
|
Brain Stem | 1 | 2012 | 859 | 0.020 |
Why?
|
Goals | 1 | 2011 | 717 | 0.020 |
Why?
|
Nonverbal Communication | 1 | 2005 | 62 | 0.020 |
Why?
|
Communication Disorders | 1 | 2005 | 50 | 0.020 |
Why?
|
Reading | 1 | 2008 | 543 | 0.010 |
Why?
|
Drug Administration Schedule | 3 | 1999 | 4860 | 0.010 |
Why?
|
Cerebellum | 1 | 2012 | 1522 | 0.010 |
Why?
|
Self Report | 1 | 2016 | 3773 | 0.010 |
Why?
|
Chronic Disease | 2 | 2009 | 9384 | 0.010 |
Why?
|
Fourier Analysis | 1 | 2004 | 439 | 0.010 |
Why?
|
Placebos | 2 | 1999 | 1667 | 0.010 |
Why?
|
Drug Therapy, Combination | 3 | 1999 | 6316 | 0.010 |
Why?
|
Genetic Testing | 1 | 2016 | 3591 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2012 | 2744 | 0.010 |
Why?
|
Demography | 1 | 2007 | 1641 | 0.010 |
Why?
|
Psychometrics | 1 | 2011 | 3063 | 0.010 |
Why?
|
Amino Acids | 2 | 1999 | 1716 | 0.010 |
Why?
|
Empathy | 1 | 2005 | 474 | 0.010 |
Why?
|
Sensory Thresholds | 1 | 2002 | 377 | 0.010 |
Why?
|
Gene Expression | 1 | 2013 | 7598 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2017 | 14783 | 0.010 |
Why?
|
Genetic Variation | 1 | 2016 | 6611 | 0.010 |
Why?
|
United States | 1 | 2008 | 73039 | 0.010 |
Why?
|
Prospective Studies | 1 | 2024 | 54926 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2016 | 6669 | 0.010 |
Why?
|
Image Enhancement | 1 | 2010 | 2880 | 0.010 |
Why?
|
Treatment Outcome | 4 | 2017 | 65371 | 0.010 |
Why?
|
Risk Factors | 2 | 2016 | 74944 | 0.010 |
Why?
|
Mutation | 1 | 2022 | 30238 | 0.010 |
Why?
|
Terminology as Topic | 1 | 2004 | 1542 | 0.010 |
Why?
|
Electric Stimulation | 1 | 2002 | 1741 | 0.010 |
Why?
|
Models, Biological | 1 | 2012 | 9495 | 0.010 |
Why?
|
Age Factors | 1 | 2012 | 18412 | 0.010 |
Why?
|
Phenotype | 1 | 2013 | 16726 | 0.010 |
Why?
|
Glycine | 1 | 1999 | 672 | 0.010 |
Why?
|
Movement | 1 | 2002 | 1490 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2008 | 7852 | 0.010 |
Why?
|
Nootropic Agents | 1 | 1995 | 159 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2016 | 39348 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 2 | 1996 | 10760 | 0.010 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 1991 | 4640 | 0.010 |
Why?
|
Disease Progression | 1 | 2009 | 13671 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2017 | 59629 | 0.010 |
Why?
|
Veterans | 1 | 2000 | 2669 | 0.000 |
Why?
|
Ambulatory Care | 1 | 1996 | 2783 | 0.000 |
Why?
|
Retrospective Studies | 1 | 2013 | 81762 | 0.000 |
Why?
|